Download PDF
Thromb Haemost 1988; 60(02): 220-225
DOI: 10.1055/s-0038-1647033
Original Article
Schattauer GmbH Stuttgart

Localization of the Inhibitory Site(s) of Pentosan Polysulphate in Blood Coagulation

R Wagenvoord
The Biomedical Center, Department of Biochemistry, Maastricht, The Netherlands
,
H Hendrix
The Biomedical Center, Department of Biochemistry, Maastricht, The Netherlands
,
C Soria
*   The Laboratoire d'Hématologie, Lariboisière, Dept, of Prof. J. Caen, Paris, France
,
H C Hemker
The Biomedical Center, Department of Biochemistry, Maastricht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 14 January 1988

Accepted after revision 31 May 1988

Publication Date:
28 June 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

We studied the inhibitory effect of pentosan polysulphate (PPS, Hémoclar®) on thrombin formation in blood coagulation. In contrast to a current hypothesis (1) the anti thrombin III independent effect of PPS on blood coagulation is not caused by preventing the binding of the factors IX, IXa, X, Xa, VIII, V, Va and II onto procoagulant phospholipids.

We investigated the activation by thrombin of factors I, V and VIII. A strong inhibitory effect of PPS on factor VIII activation could be observed. Inhibition of the activation of factor V to the same extent requires about 30-fold higher concentrations of PPS, whereas the activation (clotting) of fibrinogen is not inhibited. The effect of PPS on factor VIIIa is two-fold: A) it inhibits its formation and B) it inhibits its function probably by the formation of a factor VIIIa-PPS complex.

Prothrombinase, constituted of purified factors Xa, Va and phospholipids was not inhibited by PPS, neither were incomplete forms of this enzyme, lacking phospholipids or factor Va. The complete factor X activating enzyme (factors IXa, VIIIa and phospholipids), however, was strongly inhibited, but incomplete forms, lacking factor VIII, were not. The inhibition of the complete enzyme can be explained by reversible binding of PPS to factor VIIIa (causing an inhibition of its function) and it is not an effect on the enzymatic function of the complete enzyme. On saturation of the enzyme with an excess of factor VIIIa no inhibition by PPS is noticed.

We postulate therefore that the antithrombin III independent inhibitory effect of PPS on thrombin generation on blood coagulation is by interaction with factor VIIIa. This effect is additional to the heparin-like action of PPS, i.e. potentiation of the activity of antithrombin III and/or heparin cofactor II. At concentrations attained during therapeutic use the action of pentosan polysulphate on factor VIIIa is the only one that will significantly inhibit the coagulation mechanism.

Keywords

Pentosan polysulphate - Blood coagulation
 

  • References

  • 1 Fischer AM, Barrowcliffe TW, Thomas DP. A Comparison of pentosan polysulphate (SP 54) and heparin. I: Mechanism of action on blood coagulation.. Thromb Haemostas 1982; 47: 104-108
    PubMedGoogle Scholar
  • 2 Scully MF, Ellis V, Kakkar VV. Pentosan polysulphate: Activation of heparin cofactor II or antithrombin III according to molecular weight fractionation.. Thromb Res 1986; 41: 489-499
    CrossrefPubMedGoogle Scholar
  • 3 Soria C, Soria J, Rijckewaart JJ, Holmer E, Caen JP. Anticoagulant activities of a pentosane polysulphate: Comparison with standard heparin and a fraction of low molecular weight heparin.. Thromb Res 1980; 19: 455-463
    CrossrefPubMedGoogle Scholar
  • 4 Scully MF, Weerasinghe KM, Ellis V, Djazaeri B, Kakkar VV. Anticoagulant and antiheparin activities of a pentosan polysulphate.. Thromb Res 1983; 31: 87-97
    CrossrefPubMedGoogle Scholar
  • 5 Dunn F, Soria J, Soria C, Thomaidis A, Tobelem G, Caen P. Fibrinogen binding on human platelets. Influence of different heparins and pentosane polysulphate.. Thromb Res 1983; 29: 141-148
    CrossrefPubMedGoogle Scholar
  • 6 Ofosu F, Blajchman MA, Hirsh J. The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin III.. Thromb Res 1980; 20: 391-403
    CrossrefPubMedGoogle Scholar
  • 7 Walker FJ, Esmon CT. Interactions between heparin and factor Xa. Inhibition of prothrombin activation.. Biochim Biophys Acta 1979; 585: 405-415
    CrossrefPubMedGoogle Scholar
  • 8 Ofosu FA, Sie P, Modi GJ, Fernandez F, Buchanan MR, Blajchman MA, Boneu B, Hirsh j. The inhibition of thrombin dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.. Biochem J 1987; 243: 579-588
    CrossrefPubMedGoogle Scholar
  • 9 Fujikawa K, Thompson AR, Legaz ME, Meyer RG, Davie EW. Isolation and characterization of bovine Factor IX (Christmas factor).. Biochemistry 1973; 12: 4938-4945
    CrossrefPubMedGoogle Scholar
  • 10 Nossel HL. The Contact Phase of Blood Coagulation. Blackwell Scientific Publications; Oxford : 1964
    Google Scholar
  • 11 Østerud B, Rapaport SI. Activation of Factor IX by the reaction product of tissue factor and Factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1974; 12: 5260-5264
    PubMedGoogle Scholar
  • 12 Fujikawa K, Legaz ME, Kato H, Davie EW. The mechanism of activation of bovine Factor IX (Christmas factor) by bovine Factor XIa (activated plasma thromboplastin antecedent).. Biochemistry 1974; 13: 4508-4516
    CrossrefPubMedGoogle Scholar
  • 13 Fujikawa K, Legaz ME, Davie EW. Bovine Factor X1 and X2 (Stuart factor). Isolation and characterization.. Biochemistry 1972; 11: 4882-4891
    CrossrefPubMedGoogle Scholar
  • 14 Owen WG, Esmon CT, Jackson CM. The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin.. J Biol Chem 1974; 249: 594-605
    PubMedGoogle Scholar
  • 15 Vehar GA, Davie EW. Preparation and properties of bovine factor VIII (antihemophilic factor).. Biochemistry 1980; 19: 401-410
    CrossrefPubMedGoogle Scholar
  • 16 Van DieijenG, van Rijn J LM L, Govers-Riemslag JW P, Hemker HC, Rosing J. Assembly of the intrinsic factor X activating complex: Interations between factor IXa, factor VIIIa and phospholipid.. Thromb Haemostas 1985; 53: 396-400
    PubMedGoogle Scholar
  • 17 Nesheim EM, Myrmel KH, Hibbard L, Mann KG. Isolation and characterization of single chain bovine Factor V. J Biol Chem 1979; 254: 508-517
    PubMedGoogle Scholar
  • 18 Lottenberg R, Christensen U, Jackson CM, Coleman PL. Assay of Coagulation Proteases Using Peptide Chromogenic and Fluorogenic Substrates.. In: Methods in Enzymology. Lorand L. (ed). 1981. (; 80). 341-361
    Google Scholar
  • 19 Van de WaartP, Bruls H, Hemker HC, Lindhout T. Interactions of Bovine Blood Clotting Factor Va and Its Subunits with Phospholipid Vesicles.. Biochemistry 1983; 22: 2427-2432
    CrossrefPubMedGoogle Scholar
  • 20 Tans G, Janssen-Claessen T, van DieijenG, Hemker HC, Rosing J. Activation of Factor IX by Factor XIa - A spectrophotometric assay for Factor IX in human plasma.. Thromb Haemostas 1982; 48: 127-132
    PubMedGoogle Scholar
  • 21 Lindhout T, Govers-Riemslag JW P, Van de WaartP, Rosing J, Hemker HC. Factor Va - Factor Xa inrteraction. Effects of phospholipid vesicles of varying composition.. Biochemistry 1982; 21: 5494-5502
    CrossrefPubMedGoogle Scholar
  • 22 Comfurius P, Zwaal RFA. The enzymatic synthesis of phosphatidyl serine and purification by CM-cellulose column chromatography.. Biochim Biophys Acta 1977; 488: 36-42
    CrossrefPubMedGoogle Scholar
  • 23 Van der SteenATM, De Jong W AC, De KruijffB, Van Deenen LLM. Lipid dependence of glycophorin-induced transbilayer movement of lysophosphatidyl choline in large unilamellar vesicles.. Biochim Biophys Acta 1981; 647: 63-72
    CrossrefPubMedGoogle Scholar
  • 24 Deamer D, Bangham AD. Large volume liposomes by an ether vaporization method.. Biochim Biophys Acta 1976; 443: 629-634
    PubMedGoogle Scholar
  • 25 Böttcher CJ F, Van GentCM, Pries C. A rapid and sensitive submicrophosphorus determination. Anal Chim Acta 1961; 24: 203-207
    CrossrefPubMedGoogle Scholar
  • 26 Baruch D, Lindhout T, Wagenvoord R, Hemker HC. Inhibition of Thrombin Catalyzed Reactions in Blood Coagulation and Platelet Activation by Heparin Fractions in the Absence of Antithrombin III.. Haemostasis 1986; 16: 71-81
    PubMedGoogle Scholar
  • 27 Nelsestuen GL, Broderius M. Interaction of prothrombin and blood clotting Factor X with membranes.. Biochemistry 1977; 16: 4172-4177
    CrossrefPubMedGoogle Scholar
  • 28 Bloom JW, Nesheim ME, Mann KG. Phospholipid binding properties of bovine Factor V and Factor Va.. Biochemistry 1979; 18: 4419-4425
    CrossrefPubMedGoogle Scholar